期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

原发性肝癌患者服用索拉非尼前后血清bFGF浓度变化 被引量：2

下载PDF
导出
摘要 目的探讨原发性肝癌患者索拉非尼治疗前后血清碱性纤维母细胞生长因子(bFGF)的变化及其临床意义。方法采用双抗体夹心酶联免疫法(ELISA)测定64例原发性肝癌患者行索拉非尼治疗前后血清bFGF的含量比较分析。结果行索拉非尼治疗后,患者血清bFGF含量降低(P<0.05)。结论索拉非尼治疗能抑制肝癌肿瘤的浸润和转移。
作者 丁苇 朱陈 付守忠 王斌 王晓维
机构地区 江苏省南通市第三人民医院介入科 江苏省南通市第三人民医院消化内科
出处 《齐齐哈尔医学院学报》 2010年第18期2899-2899,共1页 Journal of Qiqihar Medical University
关键词 原发性肝癌 索拉非尼 BFGF
分类号 R512.62 [医药卫生—内科学]
  • 相关文献

参考文献5

  • 1张晶晶,王波,刘增娟.腹膜间皮细胞对卵巢癌细胞血管生成因子表达及分泌的影响[J].中华肿瘤杂志,2006,28(10):737-740. 被引量：3
  • 2Dietz,Rudat V,Conradt C,et al.Prognostic relevance of serumlevels of the angiogenic peptide bFGF in advanced carcinoma ofthe head and neck treated by primary radio-chemotherapy[J].Head Neck,2000,22(7):666-673.
  • 3Obermair A,Speiser P,Reisenberger K,et al.Influence ofintratu-moral basic fibroblast growth factor concentration on survival in o-varian cancer patients[J].Cancer Lett,1998,130(1-2):69-76.
  • 4Llovet J,Ricci S,Mazzaferro V,et al.Sorafenib in advanced Hepatocellular Carcinoma[J].N Engl J Med,2008,359(4):378-390.
  • 5Cheng AL,Kang Y,Chen Z,et al.Randomized phase nI trial of sorafenib versI1s placebo in Asian patients with advanced hepa-tocellular carcinoma[J].Journal of Clinical Oneology,2008,26(19 Supp1):4509.

二级参考文献8

  • 1Liss C,Fekete MJ,Hasina R,et al.Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages.Int J Cancer,2001,93:781-785.
  • 2Aoyagi K,Kouhuji K,Yano S,et al.VEGF significance in peritoneal recurrence from gastric cancer.Gastric Cancer,2005,8:155-163.
  • 3Carpenter PM,Dao AV.The role of hyaluronan in mesotheliuminduced motility of ovarian carcinoma cells.Anticancer Res,2003,23:3985-3990.
  • 4Hirashima Y,Kobayashi H,Suzuki M,et al.Transforming growth factor-β1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an up-regulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells.J Biol Chem,2003,278:26793-26802.
  • 5Yao V,Platell C,Hall JC.Peritoneal mesothelial cells produce inflammatory related cytokines.ANZ J Surg,2004,74:997-1002.
  • 6Lee HT,Lee JG,Na M,et al.FGF-2 induced by interleukin-1 beta through the action of phosphatidylinositol 3-kinase mediates endothelial mesenchymal transformation in corneal endothelial cells.J Biol Chem,2004,279:32325-32332.
  • 7郭群英,叶任高,黄凌虹,郑树森,汪涛.透明质酸合成酶-2在人腹膜间皮细胞透明质酸合成及胞外基质形成中的作用[J].中华肾脏病杂志,2002,18(5):331-336. 被引量：9
  • 8林卫,彭芝兰,王光林,毕建红,刘珊玲,王红静.bFGF-MAb抑制卵巢癌细胞及其腹腔移植瘤生长的实验研究[J].四川大学学报（医学版）,2003,34(4):625-627. 被引量：4

共引文献2

同被引文献26

  • 1Llovet JM,Ricci S,Mazzaferro V. Sorafenib in advanced hepatocellular carcinoma[J].New England Journal of Medicine,2008,(04):378-390.
  • 2Wilhelm SM,Carter C,Tang L. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis[J].Cancer Research,2004,(19):7099-7109.doi:10.1158/0008-5472.CAN-04-1443.
  • 3Liu L,Cao Y,Chen C. Sorafenib blocks the RAF/MEK/ERK pathway,inhibits tumor angiogenesis,and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5[J].Cancer Research,2006,(24):11851-11858.
  • 4Zhou C,Liu J,Li Y. microRNA-1274a,a modulator of sorafenib induced a disintegrin and metalloproteinase 9(ADAM9) down-regulation in hepatocellular carcinoma[J].FEBS Letters,2011,(12):1828-1834.
  • 5Liu H,Peng HW,Cheng YS. Stabilization and enhancement of the antiapoptotic activity of mcl-1 by TCTP[J].Molecular and Cellular Biology,2005,(08):3117-3126.doi:10.1128/MCB.25.8.3117-3126.2005.
  • 6Fleischer B,Schulze-Bergkamen H,Schuchmann M. Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma[J].International Journal of Oncology,2006,(01):25-32.
  • 7Sieghart W,Losert D,Strommer S. Mcl-1 overexpression in hepatocellular carcinoma:a potential target for antisense therapy[J].Journal of Hepatology,2006,(01):151-157.
  • 8Yamazaki K,Nagao T,Yamaguchi T. Expression of basic fibroblast growth factor(bFGF-2) -associated with tumor proliferation in human pancreatic carcinoma[J].VIRCHOWS ARCHIV-AN INTERNATIONAL Journal OF PATHOLOGY,1997,(02):95-101.
  • 9Obermair A,Speiser P,Reisenberger K. Influence of intratumoral basic fibroblast growth factor concentration on survival in ovarian cancer patients[J].Cancer Letters,1998,(1/2):69-76.
  • 10Park JI,Lee MG,Cho K. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2,p38-NF-kappaB,JNK,and Ras signaling pathways[J].Oncogene,2003,(28):4314-4332.

引证文献2

二级引证文献4

齐齐哈尔医学院学报
2010年 第18期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部